Misinformation in some neurovascular catheter marketing materials could pose a risk to patients, US FDA said in a March 1 letter to providers.
The letter clarifies indication-for-use differences between neurovascular thrombus retrieval catheters and neurovascular guide catheters, both 510(k) devices. FDA has cleared thrombus retrieval catheters to remove thrombus or restore blood flow...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?